Prothena insider buys 50,000 shares in open market
PROTHENA CORP PUBLIC LTD CO major shareholder William P. Scully reported an open-market purchase of 50,000 ordinary shares on June 4, 2026 at a weighted average price of $9.3059 per share.
Rhea-AI Filing Summary
PROTHENA CORP PUBLIC LTD CO major shareholder William P. Scully reported an open-market purchase of 50,000 ordinary shares on June 4, 2026 at a weighted average price of $9.3059 per share. Following this transaction, he holds 936,000 shares directly.
He also reports indirect holdings of 52,000 shares by his spouse and 80,000 shares by Manatee Equity Fund LLC, and disclaims beneficial ownership of these indirect positions except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares, par value $0.01 per share | 50,000 | $9.3059 | $465K |
| holding | Ordinary Shares, par value $0.01 per share | -- | -- | -- |
| holding | Ordinary Shares, par value $0.01 per share | -- | -- | -- |
Footnotes (2)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.1000 to $9.4097, inclusive. The reporting person undertakes to provide to Prothena Corp Public Ltd Co, any security holder of Prothena Corp Public Ltd Co, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
beneficial ownership financial
pecuniary interest financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did William P. Scully report for PROTHENA CORP PUBLIC LTD CO (PRTA)?
Does the Prothena insider Form 4 mention beneficial ownership disclaimers?
AI-generated analysis. How Rhea-AI works. Not financial advice.